Lixte Biotechnology Holdings Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
03 Oct 23 | BuyUS$24,116 | René Bernards | Individual | 10,000 | US$2.51 | |
03 Oct 23 | BuyUS$28,000 | Bastiaan van der Baan | Individual | 10,000 | US$2.80 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
General Public | 452 | 0.0201% |
Private Companies | 52,525 | 2.34% |
Individual Insiders | 220,866 | 9.82% |
Institutions | 1,975,447 | 87.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
738,000 | US$2.0m | 0% | no data | |||
546,453 | US$1.5m | 0% | 0.22% | |||
171,000 | US$472.0k | 0% | no data | |||
112,000 | US$309.1k | 0% | no data | |||
101,000 | US$278.8k | 0% | no data | |||
99,432 | US$274.4k | 0% | no data | |||
83,200 | US$229.6k | 0% | no data | |||
69,000 | US$190.4k | 0% | no data | |||
50,917 | US$140.5k | 0% | no data | |||
50,917 | US$140.5k | 0% | no data | |||
46,785 | US$129.1k | -29.2% | no data | |||
27,538 | US$76.0k | 0% | no data | |||
25,000 | US$69.0k | 0% | no data | |||
14,286 | US$39.4k | 0% | no data | |||
14,166 | US$39.1k | 0% | no data | |||
11,000 | US$30.4k | 0% | no data | |||
9,997 | US$27.6k | 2.17% | no data | |||
9,000 | US$24.8k | 0% | no data | |||
9,000 | US$24.8k | 0% | no data | |||
9,000 | US$24.8k | 0% | no data | |||
9,000 | US$24.8k | 0% | no data | |||
8,708 | US$24.0k | 0% | no data | |||
7,480 | US$20.6k | 0% | no data | |||
7,106 | US$19.6k | 0% | no data | |||
5,500 | US$15.2k | 10% | 0.02% |